Valerian
drugOn this page
Also known as 4M98M04Z3Z7D1DL7VY9SChinese valerianChinese valerian wholeCommon valerian wholeFEMA NO. 3099FMM0HE453UGarden heliotrope wholeGarden valerian wholeIndian valerian wholeJapanese valerian wholeMexican valerian wholePacific valerian wholePowdered valerian extractSugandhabala wholeTagara wholeValerian wholeValeriana officinalisValeriana officinalis extract
Summary
Valerian (CHEMBL2108165) is a phase-3 clinical-stage unknown; indicated across 1 condition including anxiety.
At a glance
- Status: Max clinical phase 3 (not approved)
- Modality: Unknown
- Indications: 1 condition
- Clinical trials: 7
Identifiers
Drug identity and classification
| Field | Value |
|---|---|
| ChEMBL ID | CHEMBL2108165 |
| Name | Valerian |
| Type | Unknown |
| Max phase | 3 |
Also known as: 4M98M04Z3Z, 7D1DL7VY9S, Chinese valerian, Chinese valerian whole, Common valerian whole, FEMA NO. 3099, FMM0HE453U, Garden heliotrope whole, Garden valerian whole, Indian valerian whole, Japanese valerian whole, Mexican valerian whole
Targets
Targets
No target linkage available.
Bioactivity
No ChEMBL bioactivity rows at pChembl ≥ 5 (expected for biologics / antibodies).
Target pathways
No target-pathway data for this drug (no mapped target genes).
Indications & clinical
Indications
1 indication (0 at ChEMBL trial phase 4). Phase below is the highest clinical-trial phase recorded for this drug against each disease — not the molecule’s overall approval status (that is in the Summary).
| Indication | Trial phase | MONDO | EFO |
|---|---|---|---|
| anxiety | 3 | MONDO:0011918 | EFO:0005230 |
Clinical trials
Total trials: 7.
Phase distribution
| Phase | Trials |
|---|---|
| PHASE3 | 3 |
| Not specified | 3 |
| PHASE2 | 1 |
Top trials by phase / activity
| NCT | Phase | Status | Title |
|---|---|---|---|
| NCT00075842 | PHASE3 | COMPLETED | (Valerian) for Improving Sleep in Patients With Cancer Receiving Adjuvant Therapy |
| NCT00997490 | PHASE3 | TERMINATED | Study of the Antidepressant Efficacy of a Combination Herbal Drug Preparation (NEURAPAS Balance) |
| NCT01178632 | PHASE3 | UNKNOWN | Therapeutic Effect of an Herbal Medicine on Anxiety |
| NCT00070928 | PHASE2 | COMPLETED | Valerian to Improve Sleep in Patients With Parkinson’s Disease |
| NCT07515612 | Not specified | RECRUITING | The Impact of Valerian and Chamomile on Children’s Anxiety in the Dental Clinic. |
| NCT02981238 | Not specified | COMPLETED | Phytotherapy Strategy for Sleep Disorders Related to Anxiety With a Combination of Eschscholtzia and Valerian Extracts |
| NCT05185219 | Not specified | UNKNOWN | The Effect of Valerian on Insomnia in Menopausal Women |
Clinical evidence (CIViC)
No CIViC predictive evidence (expected for non-precision-medicine drugs).
Pharmacology
Pharmacogenomics
No PharmGKB pharmacogenomic data curated for this drug.
Related molecules
Related molecules
No competitor molecules sharing a primary target (ChEMBL phase ≥2 or PubChem drug-class).
Related Atlas pages
- Diseases: anxiety